All Stories

  1. How SGLT-2 Inhibitors (Gliflozins) Treat Type 2 Diabetes: Focus on the New Drug Bexagliflozin

    Article • Cardiovascular & Hematological Agents in Medicinal Chemistry, February 2026, Bentham Science Publishers

    Arun Kumar , Pushpendra Soni, Samman Samman